Salix Pharmaceuticals
Manufacturing · New Jersey, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
400 Somerset Corporate Blvd, Bridgewater...Phone Number
(800) 321-4576Website
www.salix.comRevenue
$341.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Salix Pharmaceuticals
Salix Pharmaceuticals Ltd is a specialty pharmaceutical company. It provides prevention and treatment of gastrointestinal (GI) diseases and disorders. The company was founded in 1989 and is headquartered in Bridgewater, New Jersey.Explore more
Salix Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Salix Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Salix Pharmaceuticals
Check if Salix Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Salix Pharmaceuticals launches new products
Click to see if Salix Pharmaceuticals had a recent Job posting/layoffs
Salix Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Salix Pharmaceuticals has new funding data
Check out if Salix Pharmaceuticals is spiking on competitors!
Earning: See what the market has to say on Salix Pharmaceuticals recently announced quarterly report
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Salix Pharmaceuticals
Compare insights from companies similar to Salix Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Salix Pharmaceuticals
$341.6M
501-1,000
Private
$60M
1989
RS
Richard ScruggsExecutive VP, Business Development
Company Profile Activity
Activity Insights
Salix Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Salix Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Salix Pharmaceuticals.
Salix Pharmaceuticals financials insights
Gather financial insights about Salix Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2008
Debt
$60M
Salix Pharmaceuticals Tech Stack
A closer look at the technologies used by Salix Pharmaceuticals
See more technologies
Most Recent Scoops
Event
Product Marketing, Events, Research & Development, Medical Research, Clinical Operations, Healthcare Technology
Pain Point
Pain Point, Lawsuits, Legal Affairs
Event
Events
Event
will be attending the SHM Converge 2023 conference as an exhibitor. The event will occur from March 26 to March 29, 2023.
Project
Customer Service
Salix Pharmaceuticals News & Media
Danaher Announces Conversion Date for Series B Mandatory ... - Investing News Network
Danaher Corporation announced today that its 5.00% Series B Mandatory Convertible Preferred Stock will automatically convert into shares of the Company's common stock on April 17, 2023 . The conversion rate for each share of Preferred Stock will be 5.0175 shares of the Company's common stock. Cash will be paid in lieu of fractional shares of common stock. As previously announced, on April 17, 2023 holders of record ...SALIX PHARMACEUTICALS RELEASES LIVER HEALTH ANNUAL TRENDS REPORT UNDERSCORING CHALLENGES IN CARING FOR GROWING CHRONIC LIVER DISEASE AND CIRRHOTIC PATIENT POPULATION
Released During Liver Health Awareness Month and Based Primarily on HCP-Market Research, Salix Pharmaceuticals' Liver Health Annual Trends Report Finds More than One-Third of Gastroenterologists Surveyed Have Seen an Increase in Patient Hospitalizations Due to Cirrhosis Over the Past Year...SALIX PHARMACEUTICALS APPLAUDS IMPLEMENTATION OF K76.82 - A NEW ICD-10 CODE FOR HEPATIC ENCEPHALOPATHY
Centers for Medicare & Medicaid Services (CMS) Launch of New Code Coincides with Liver Awareness Month, a Time to Make Liver Health a National Health Care Priority LAVAL, QC, Oct. 3, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its...Bausch Health Responds to Norwich Pharmaceuticals Tentative FDA Approval for a 200 mg Rifaximin
LAVAL, QC, Sept. 9, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("the Company"), and its gastroenterology business Salix Pharmaceuticals, today responded to the U.S. Food and Drug Administration's (FDA) tentative approval of the Norwich Pharmaceuticals rifaximin 200...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Salix Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Salix Pharmaceuticals Ltd is a specialty pharmaceutical company. It provides prevention and treatment of gastrointestinal (GI) diseases and disorders. The company was founded in 1989 and is headquartered in Bridgewater, New Jersey.... Read More
